Q1 2023 EPS Estimates for Pediatrix Medical Group, Inc. Cut by Analyst (NYSE:MD)

Posted by on Apr 27th, 2023

Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) – Equities researchers at Zacks Research lowered their Q1 2023 EPS estimates for Pediatrix Medical Group in a report issued on Monday, April 24th. Zacks Research analyst D. Chatterjee now expects that the company will post earnings of $0.17 per share for the quarter, down from their prior estimate of $0.19. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.43 per share. Zacks Research also issued estimates for Pediatrix Medical Group’s Q2 2023 earnings at $0.33 EPS, FY2023 earnings at $1.33 EPS and Q1 2025 earnings at $0.34 EPS.

Pediatrix Medical Group (NYSE:MD – Get Rating) last announced its earnings results on Friday, February 17th. The company reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. Pediatrix Medical Group had a net margin of 3.36% and a return on equity of 14.97%. The firm had revenue of $513.84 million for the quarter, compared to analyst estimates of $501.68 million.

Several other brokerages also recently issued reports on MD. Credit Suisse Group dropped their target price on shares of Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 22nd. StockNews.com assumed coverage on shares of Pediatrix Medical Group in a research note on Thursday, March 16th. They issued a “hold” rating on the stock. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $19.00.

Pediatrix Medical Group Trading Up 2.4 %

NYSE:MD opened at $14.05 on Wednesday. The company’s 50-day simple moving average is $14.88 and its 200 day simple moving average is $15.55. The firm has a market capitalization of $1.18 billion, a P/E ratio of 17.56, a PEG ratio of 2.21 and a beta of 1.75. Pediatrix Medical Group has a one year low of $13.59 and a one year high of $23.95. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.00 and a quick ratio of 1.00.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Pediatrix Medical Group by 2.3% during the first quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock valued at $224,045,000 after purchasing an additional 212,150 shares during the last quarter. ArrowMark Colorado Holdings LLC raised its holdings in shares of Pediatrix Medical Group by 11.2% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 4,048,957 shares of the company’s stock valued at $60,168,000 after purchasing an additional 407,239 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Pediatrix Medical Group by 4.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,554,701 shares of the company’s stock valued at $52,823,000 after purchasing an additional 153,723 shares during the last quarter. State Street Corp raised its holdings in shares of Pediatrix Medical Group by 2.2% during the third quarter. State Street Corp now owns 3,373,969 shares of the company’s stock valued at $55,704,000 after purchasing an additional 72,731 shares during the last quarter. Finally, Lazard Asset Management LLC raised its holdings in shares of Pediatrix Medical Group by 24.3% during the first quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock valued at $76,631,000 after purchasing an additional 637,798 shares during the last quarter. 95.99% of the stock is owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Read More

Earnings History and Estimates for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.